Study Evaluating the Effect of IMA-026 on Allergen-Induced Late Asthma Response in Mild Asthma

NCT00725582 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: IMA-026
OTHER: Placebo

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer